Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR1361736

GTEX

6bc12cb3-80f6-5e9d-b03b-26386fa9e70d

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • KRAS_SIGNALING_DN+0.139
  • DNA_REPAIR+0.087
  • MYOGENESIS+0.078
  • PROTEIN_SECRETION+0.072
  • MITOTIC_SPINDLE+0.055
  • SPERMATOGENESIS+0.036
  • UNFOLDED_PROTEIN_RESPONSE-0.022
  • APICAL_JUNCTION-0.031
  • HEME_METABOLISM-0.038
  • MYC_TARGETS_V2-0.038

Top 10 suppressed

  • INTERFERON_ALPHA_RESPONSE-0.634
  • INFLAMMATORY_RESPONSE-0.536
  • IL6_JAK_STAT3_SIGNALING-0.531
  • INTERFERON_GAMMA_RESPONSE-0.525
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.483
  • TNFA_SIGNALING_VIA_NFKB-0.479
  • ALLOGRAFT_REJECTION-0.468
  • COAGULATION-0.453
  • ANGIOGENESIS-0.452
  • KRAS_SIGNALING_UP-0.438

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1490568
brain-umap@2
GTEX0.985
2SRR1359367
brain-umap@2
GTEX0.983
3SRR1464305
brain-umap@2
GTEX0.983
4SRR1479239
brain-umap@2
GTEX0.983
5SRR1319672
brain-umap@2
GTEX0.983
6SRR1441224
brain-umap@2
GTEX0.979
7SRR1401062
brain-umap@2
GTEX0.978
8SRR1352415
brain-umap@2
GTEX0.977
9SRR1401552
brain-umap@2
GTEX0.976
10SRR1327811
brain-umap@2
GTEX0.976

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 6 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
KRAS_SIGNALING_DN0.139Remibrutinib— uncovered
DNA_REPAIR0.087Idelalisib— uncovered
MYOGENESIS0.078Inavolisib— uncovered
PROTEIN_SECRETION0.072Remibrutinib— uncovered
MITOTIC_SPINDLE0.055Inavolisib— uncovered
SPERMATOGENESIS0.036Inavolisib— uncovered